期刊
AUTOIMMUNITY REVIEWS
卷 10, 期 2, 页码 65-73出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2010.08.003
关键词
Systemic sclerosis; Cytokines; Fibrosis; T lymphocytes
类别
资金
- INSERM
- Association des Sclerodermiques de France (ASF)
- Groupe Francais de Recherche sur la Sclerodermie (GFRS)
- SRD Societe de Recherche en Dermatologie
Although the pathogenesis of systemic sclerosis (SSc) remains unknown, cytokine production and release are key events in this autoimmune disease, characterized by T cell activation and auto-antibodies production leading to microvascular damage, inflammation and fibrosis. We review herein experimental and clinical data, aiming to analyze the relationship between cytokine release and SSc pathogenesis. Measurement of circulating or in situ cytokine levels provides evidence for a balance between Th1/Th2 or Th17/Treg cytokines in the development of SSc. Indeed, the Th2 cytokine response, with the production of IL-4, IL-10 and TGF-beta, leads to tissue fibrosis, whereas Th1 and Th17 cytokines promote inflammation in SSc patients. Thus, cytokine levels have been assessed as diagnostic or prognostic markers in SSc patients. Restoration of the Th1/Th2/Th17/Treg balance is one of the hallmarks of treatment effectiveness and development of cytokine modulators could be considered for new therapeutic approaches in SSc patients. (c) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据